| # | Drug | Count |
|---|---|---|
| 0 | INTERFERON BETA-1A | 26 |
| 1 | NATALIZUMAB | 15 |
| 2 | RITUXIMAB | 9 |
| 3 | INTERFERON BETA-1B | 8 |
| 4 | BACLOFEN | 7 |
| 5 | ERGOCALCIFEROL | 6 |
| 6 | INFLIXIMAB | 6 |
| 7 | ONABOTULINUMTOXINA | 6 |
| 8 | ROMIPLOSTIM | 6 |
| 9 | BENRALIZUMAB | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAMLINTIDE ACETATE | 2 | 0.0196 |
| 1 | BACTERIOSTATIC WATER | 1 | 0.0024 |
| 2 | METRELEPTIN | 3 | 0.0024 |
| 3 | MECASERMIN | 1 | 0.0012 |
| 4 | DINUTUXIMAB | 1 | 0.0012 |
| 5 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| 6 | INCOBOTULINUMTOXINA | 3 | 0.0005 |
| 7 | INTERFERON BETA-1B | 8 | 0.0004 |
| 8 | ROMIPLOSTIM | 6 | 0.0004 |
| 9 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 3 | 0.0024 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 2 | Thrombopoietin Receptor Agonist [EPC] | 6 | 0.0004 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 5 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 4 | 0.0002 |
| 6 | Integrin Receptor Antagonist [EPC] | 15 | 0.0002 |
| 7 | PCSK9 Inhibitor [EPC] | 4 | 0.0002 |
| 8 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 9 | Interferon beta [EPC] | 26 | 0.0001 |